Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia

Am J Cardiol. 2002 May 15;89(10):1205-7. doi: 10.1016/s0002-9149(02)02306-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Angina Pectoris / blood
  • Angina Pectoris / complications*
  • Angina Pectoris / drug therapy*
  • Atorvastatin
  • C-Reactive Protein / drug effects*
  • Cholesterol, HDL / blood
  • Cholesterol, HDL / drug effects
  • Cholesterol, LDL / blood
  • Cholesterol, LDL / drug effects
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Follow-Up Studies
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Lovastatin / therapeutic use*
  • Middle Aged
  • Myocardial Ischemia / blood
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / etiology*
  • Pyrroles / therapeutic use*
  • Time Factors
  • Treatment Outcome
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Heptanoic Acids
  • Hypolipidemic Agents
  • Pyrroles
  • Triglycerides
  • C-Reactive Protein
  • Lovastatin
  • Atorvastatin